Skip to main content

Advertisement

SpringerLink
Log in

Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Cyclin E is known as a G1-S phase regulatory protein and its abnormal expression has been implicated in cellular proliferation. This study aimed to investigate the correlation of cyclin E expression with tumorigenesis of the endometrium, proliferative activity, and clinicopathological features of endometrial adenocarcinoma.

Methods

Immunohistochemical staining for cyclin E in addition to cyclin-dependent kinase 2 (cdk2), Ki67, p27, and p53 was performed by the labeled streptavidin-biotin method on formalin-fixed, paraffin-embedded tissues of normal endometria (20 cases), endometrial hyperplasias (20 cases), and endometrial adenocarcinomas (endometrioid type) (127 cases). Positive staining was expressed as a labeling index (LI) based on percentages of positive nuclei in tumor cells.

Results

Immunohistochemistry showed that the nuclei of the cells were positive for cyclin E. Both proliferative and secretory endometria, and endometrial hyperplasia regardless of type were negligible for cyclin E expression. The expression in normal endometrium and hyperplasia was significantly less than that in endometrial adenocarcinomas (P<0.0001). LIs of cyclin E in well-differentiated, moderately differentiated, and poorly differentiated endometrial adenocarcinomas were 31.5±33.3%, 37.8±31.9%, and 51.1±30.8%, respectively. Cyclin E expression increased significantly more in histological grades. The LI of cyclin E in carcinoma was positively correlated with that of cdk2, Ki67, and p53 but not with p27. The cyclin E expression was correlated with myometrial invasion and lymph-vascular space involvement, but not with FIGO stage, lymph node metastasis, coexisting endometrial hyperplasia, estrogen receptor, progesterone receptor, and menopause.

Conclusion

Cyclin E as a complex with cdk2 is associated with carcinogenesis and disease progression in endometrial adenocarcinoma, and might be a prognostic indicator of endometrial adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig.

Similar content being viewed by others

References

  • Ahn HJ, Kwon KW, Choi YJ, Cho NH (1998) Expression of cyclin E and cyclin-dependent kinase inhibitor, p27KIP1 in uterine endometrial carcinoma: relationship with p53 status. Int J Surg Pathol 6:205–212

    CAS  Google Scholar 

  • Akaboshi M, Watanabe J, Fujisawa T, Hattori M, Ohno E, Kuramoto H (2001) Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma. J Jpn Soc Clin Cytol 40:121–127 (in Japanese)

    Google Scholar 

  • Anayama T, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S (1998) Positive correlation between p27KIP1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 79:439–443

    Article  CAS  PubMed  Google Scholar 

  • Dellas A, Schultheiss E, Leivas MR, Moch H, Torhorst J (1998) Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res 18:3991–3996

    CAS  PubMed  Google Scholar 

  • Del Pizzo JJ, Borkowski A, Jacobs SC, Kyprianou N (1999) Loss of cell cycle regulators p27Kip1 and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 155:1129–1136

    PubMed  Google Scholar 

  • Dobashi Y, Shoji M, Jiang SX, Kobayashi M, Kawakubo Y, Kameya T (1998) Active cyclin A-cdk2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am J Pathol 153:963–972

    CAS  PubMed  Google Scholar 

  • Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H, Kawakami Y (2001) A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis. Cancer Res 61:2500–2504

    CAS  PubMed  Google Scholar 

  • Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92:770–777

    CAS  PubMed  Google Scholar 

  • FIGO news (1989) Int J Gynecol Obstet 28:189–193

    Google Scholar 

  • Fujisawa T, Watanabe J, Akaboshi M, Ohno E, Kuramoto H (2001) Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 127:668–674

    CAS  PubMed  Google Scholar 

  • Gillett CE, Smith P, Peters G, Lu X, Barnes DM (1999) Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol 187:200–206

    Article  CAS  PubMed  Google Scholar 

  • Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC (1996) Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 62:192–198

    Article  CAS  PubMed  Google Scholar 

  • Ito K, Sasano H, Yoshida Y, Sato S, Yajima A (1998) Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer Res 18:1661–1664

    CAS  PubMed  Google Scholar 

  • Jobo T, Tateoka K, Kuramoto H (1996) Study on the long-term follow-up of endometrial hyperplasia. Int J Clin Oncol 1:163–169

    Google Scholar 

  • Kawana H, Tamaru J, Tanaka T, Hirai A, Saito Y, Kitagawa M, Mikata A, Harigaya K, Kuriyama T (1998) Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am J Pathol 153:505–513

    CAS  PubMed  Google Scholar 

  • Keyomarsi K, Herliczek TW (1997) The role of cyclin E in cell proliferation, development and cancer. Prog Cell Cycle Res 3:171–191

    CAS  PubMed  Google Scholar 

  • Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380–385

    CAS  PubMed  Google Scholar 

  • Li JQ, Miki H, Ohmori M, Wu F, Funamoto Y (2001) Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. Hum Pathol 32:945–953

    Article  CAS  PubMed  Google Scholar 

  • Makiyama K, Masuda M, Takano Y, Iki M, Asakura T, Suwa Y, Noguchi S, Hosaka M (2000) Cyclin E overexpression in transitional cell carcinoma of the bladder. Cancer Lett 151:193–198

    Article  CAS  PubMed  Google Scholar 

  • Masciullo V, Sgambato A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, Carbone A, Cittadini A, Mancuso S,Scambia G, Giordano A (1999) Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res 59:3790–3794

    CAS  PubMed  Google Scholar 

  • Milde-Langosch K, Bamberger AM, Goemann C, Rossing E, Rieck G, Kelp B, Loning T (2001) Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol 127:537–544

    Google Scholar 

  • Nielsen NH, Arnerlov C, Emdin SO, Landberg G (1996) Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74:874–880

    CAS  PubMed  Google Scholar 

  • Nycum LR, Smith LM, Farley JH, Kost ER, Method MW, Birrer MJ (2001) The role of p27 in endometrial carcinoma. Gynecol Oncol 81:242–246

    Article  CAS  PubMed  Google Scholar 

  • Ohkawara S, Jobo T, Sato R, Kuramoto H (2000) Comparison of endometrial carcinoma coexisting with and without endometrial hyperplasia. Eur J Gynaecol Oncol 21:573–577

    CAS  PubMed  Google Scholar 

  • Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222–225

    CAS  PubMed  Google Scholar 

  • Resnitzky D, Gossen M, Bujard H, Reed SI (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669–1679

    CAS  PubMed  Google Scholar 

  • Russo AA, Jeffery PD, Patten AK, Massague J, Pavletich NP (1996) Crystal structures of the p27kip cyclin-dependent kinase inhibitor bound to the cyclin A-cdk complex. Nature 382:325–331

    CAS  PubMed  Google Scholar 

  • Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa T, Hirao T, Nakano H (1998) Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 82:1238–1243

    CAS  PubMed  Google Scholar 

  • Sauer K, Lehner CF (1995) The role of cyclin E in the regulation of entry into the S phase. Prog Cell Cycle Res 1:125–139

    CAS  PubMed  Google Scholar 

  • Sawasaki T, Shigemasa K, Shiroyama Y, Kusuda T, Fujii T, Parmley TH, O'Brien TJ, Ohama K (2001) Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation. J Soc Gynecol Invest 8:179–185

    Article  CAS  Google Scholar 

  • Scott KA, Walker RA (1997) Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer 76:1288–1292

    CAS  PubMed  Google Scholar 

  • Shamma A, Doki Y, Tsujinaka T, Shiozaki H, Inoue M, Yano M, Kawanishi K, Monden M (2000) Loss of p27KIP1 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 58:152–158

    Article  CAS  PubMed  Google Scholar 

  • Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S (1999) Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer 85:669–677

    Article  CAS  PubMed  Google Scholar 

  • Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ, Iacopetta BJ (1996) Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 74:562–567

    CAS  PubMed  Google Scholar 

  • Sui L, Tokuda M, Ohno M, Hatase O, Hando T (1999) The concurrent expression of p27kip1 and cyclin D1 in epithelial ovarian tumors. Gynecol Oncol 73:202–209

    Article  CAS  PubMed  Google Scholar 

  • Watanabe J, Sato H, Kanai T, Kamata Y, Jobo T, Hata H, Fujisawa T, Ohno E and Kuramoto H (2002) Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters. Br J Cancer 87:81–85

    Article  CAS  PubMed  Google Scholar 

  • Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R (1994) Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9:995–997

    CAS  PubMed  Google Scholar 

  • Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E (1996) Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch 429:13–19

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The paper is partly supported by the grant-in-aid for the Research Project of the Graduate School of Medical Sciences, Kitasato University, and for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (Grants 12670176 and 12671627), Japan.

Author information

Authors and Affiliations

  1. Department of Clinical Cytology, Kitasato University Graduate School of Medical Sciences, Sagamihara, Kanagawa, Japan

    N. Kato, Y. Nishimura, T. Fujisawa, Y. Kamata & H. Kuramoto

  2. Department of Pathology, Kitasato University School of Medicine 1-15-1, Kitasato, 228–8555, Sagamihara, Kanagawa , Japan

    J. Watanabe

  3. Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

    T. Jobo

Authors
  1. N. Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Jobo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Fujisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Kamata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Kuramoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Watanabe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, N., Watanabe, J., Jobo, T. et al. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance. J Cancer Res Clin Oncol 129, 222–226 (2003). https://doi.org/10.1007/s00432-003-0426-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-003-0426-x

Keywords

Search

Navigation